Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,791.60
(
0.00%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.89
(
0.68%
)
Bitcoin
80,790.67
(
-0.33%
)
News Focus
News Focus

Replies to post #946 on Fate Therapeutics Inc (FATE)

Replies to #946 on Fate Therapeutics Inc (FATE)
icon url

NY1972

04/15/26 12:23 AM

#947 RE: jondoeuk #946

The first 45 year old MSS CRC never had objective response from prior treatments that probably included cetuximab. So cetuximab rechallenge not happening IMO.